MedTrace Logo

Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty

NCT04507412 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2026-03-05

No results posted yet for this study

Summary

The aim of the study is to evaluate if intravenous steroid supplementation can provide advantages over routine analgesia protocols in terms of post-operative symptoms (pain and nausea), length of hospital stay, shoulder range of motion, function and patient satisfaction

Conditions

  • Arthroplasty, Replacement, Shoulder

Interventions

DRUG

dexamethasone

perioperatively 9 mg i.v subministration

Sponsors & Collaborators

  • Christian Candrian

    lead OTHER

Principal Investigators

  • Christian Candrian, Prof.Dr.med · EOC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
58 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-09
Primary Completion
2032-07-31
Completion
2032-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04507412 on ClinicalTrials.gov